1. Home
  2. MAIA vs SOTK Comparison

MAIA vs SOTK Comparison

Compare MAIA & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

SELL

Current Price

$1.01

Market Cap

69.2M

Sector

Health Care

ML Signal

SELL

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

SELL

Current Price

$4.03

Market Cap

71.0M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
MAIA
SOTK
Founded
2018
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
69.2M
71.0M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
MAIA
SOTK
Price
$1.01
$4.03
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
★ $12.00
$8.50
AVG Volume (30 Days)
★ 246.6K
98.9K
Earning Date
11-09-2026
10-14-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
★ 37.50
EPS
N/A
★ 0.07
Revenue
N/A
★ $20,909,315.00
Revenue This Year
N/A
$2.67
Revenue Next Year
N/A
$23.22
P/E Ratio
★ N/A
$61.07
Revenue Growth
N/A
★ 1.97
52 Week Low
$0.87
$3.40
52 Week High
$3.19
$7.48

Technical Indicators

Market Signals
Indicator
MAIA
SOTK
Relative Strength Index (RSI) 38.89 28.46
Support Level N/A $3.89
Resistance Level $1.48 $4.62
Average True Range (ATR) 0.06 0.28
MACD -0.00 -0.06
Stochastic Oscillator 23.11 0.66

Price Performance

Historical Comparison
MAIA
SOTK

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: